Skip to main content

Table 1

From: Evaluation of an nhs juvenile idiopathic arthritis (JIA) treatment pathway compared to published international recommendations

JIA subtype

Disease severity

N=

Poor prognostic factors

RhF positive

Median duration to MTX

Median duration to etanercept

Systemic

Low

1

0

0

N/A

N/A

N=5

Moderate

2

0

0

  
 

High

2

0

0

  

Polyarthritis & extended oligoarthritis

Low

0

0

0

6

(3-37)

7

(3-24)

N=30

Moderate

23

9

2

  
 

High

6

2

1

  
 

Unknown

1

0

0

 Â